LAB — Standard Biotools Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Standard Biotools, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	68.5	28.5	166	115	293
Net Total Accounts Receivable
Net Total Receivables	25.4	18.3	17.3	19.7	33.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	118	72.1	209	158	376
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	55.6	65.2	59.5	54.9	71.4
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	325	275	390	323	612
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	54.2	49.6	43.4	109	65.9
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	186	181	161	160	141
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	139	94.6	230	163	472
Total Liabilities & Shareholders' Equity	325	275	390	323	612
Total Common Shares Outstanding